Trends in Patch Testing With the Mayo Clinic Standard Series, 2011–2015

@article{Veverka2018TrendsIP,
  title={Trends in Patch Testing With the Mayo Clinic Standard Series, 2011–2015},
  author={Kevin K Veverka and Matthew R. Hall and James A. Yiannias and Lisa A. Drage and Rokea A El-Azhary and Jill M. Killian and Janis S Johnson and Diane L Nordberg Linehan and Nidhi Singh and Mark Denis P. Davis},
  journal={Dermatitis},
  year={2018},
  volume={29},
  pages={310–315}
}
Background Patch testing to a standard (baseline) series of allergens is the screening tool used to identify culprit allergens in patients with contact dermatitis. The allergens and concentrations used in a standard series are constantly evolving to be most relevant to the patients being patch tested. Objective The aim of this study was to analyze the 2011–2015 patch test results of the Mayo Clinic standard series. Methods We retrospectively reviewed patch test reactions of standard series… 

Patch Testing With an Extended Metal Allergen Series at the Massachusetts General Hospital (2006–2017)

Allergy to metals, including those not included in standard series, may be more prevalent than previously suspected and results may help guide future testing for suspected metal allergy, although future studies are warranted.

Relative Prevalence of Contact Allergens in North America in 2018.

The CAMP database can be used to determine the relative prevalence of contact allergens, to help develop North American core screening patch test series, and to document the medical necessity of more comprehensive patch testing for patients with recalcitrant contact allergy.

Seven Common Allergen Groups Causing Eyelid Dermatitis: Education and Avoidance Strategies

This retrospective clinical study identifies common allergens with eyelid involvement and addresses a literary gap by providing a clear approach for effective management of periorbital allergic contact dermatitis (ACD) recurrence.

Patch Testing to Methyldibromoglutaronitrile/Phenoxyethanol: North American Contact Dermatitis Group Experience, 1994–2018

A retrospective analysis of cross-sectional data compiled by the North American Contact Dermatitis Group from 1994 to 2018 found patients with a positive reaction to MDBGN/PE were significantly more likely to be male and older than 40 years and/or had hand dermatitis.

A Retrospective Review of Late Delayed Positive Patch Testing Greater Than Day 8 at Mayo Clinic From 2001 to 2020

Positive patch test readings after day 8 are uncommon, but allergens most likely to be positive are metals (gold, cobalt, palladium, beryllium), acrylates, dodecyl gallate, and gentamycin.

Men's Facial Moisturizers in the Metrosexual Era: Characteristics, Allergens, and Relevance of Men's Products in Modern Dermatology.

Men's facial moisturizers commonly contain fragrances, emulsifiers, and glucosides but relatively few allergenic preservatives, which may reflect changes in modern PCP preservation and be important for modern dermatologists to be aware, especially in a new era of male skincare.

Allergic Contact Dermatitis From Topical Drugs: An Overview.

  • A. D. de Groot
  • Medicine
    Dermatitis : contact, atopic, occupational, drug
  • 2021
An overview of allergic contact dermatitis to topical drugs is provided, discussing their prevalence of sensitization, predisposing factors, clinical manifestations (both typical and atypical), the drugs described as allergens, cross-reactivity and coreactivity, and diagnostic procedures.

The Final Patch Test Read: Day 5 or Day >7?

This study reviewed records of patients who underwent patch testing from January 2007 to December 2016 at Mayo Clinic with readings on day 5 and day 7 or later to identify allergens with positive reactions on day5 that were negative on day7 or later and allergens that were subsequently positive on day 6 or later.

References

SHOWING 1-10 OF 17 REFERENCES

Patch test results from the Mayo Clinic Contact Dermatitis Group, 1998-2000.

Changing trends and allergens in the patch test standard series: a mayo clinic 5-year retrospective review, january 1, 2001, through december 31, 2005.

Metals, fragrances, topical antibiotics, preservatives, and individual allergens used in hair-care products, topical corticosteroids, glues, plastics, and rubber were still the most common allergen groups associated with allergic patch test reactions.

North American Contact Dermatitis Group Patch Test Results 2013–2014

The NACDG patch testing results confirm that the epidemic of sensitivity to methylisothiazolinone previously documented in Europe is also occurring in North America.

North American Contact Dermatitis Group Patch Test Results: 2009 to 2010

These results affirm the value of patch testing with many allergens and Hypothetically, approximately one quarter of reactions detected by NACDG allergens would have been missed by TRUE TEST (SmartPractice Denmark).

North American Contact Dermatitis Group Patch Test Results: 2011–2012

The NACDG patch-testing results document the beginning of the epidemic of sensitivity to methylisothiazolinones in North America, which has been well documented in Europe.

North American Contact Dermatitis Group Patch‐Test Results, 2001‐2002 Study Period

The findings of patch testing from January 1, 2001, to December 31, 2002 reinforce the need for a more comprehensive group of diagnostic allergens than those found in the standard screening kits.

Patch Testing in Children From 2005 to 2012: Results From the North American Contact Dermatitis Group

Differences inpositive patch test and relevant positive patch test frequencies between children and adults as well as test periods confirm the importance of reporting periodic updates of patch testing in children to enhance clinicians’ vigilance to clinically important allergens.

Benzalkonium Chloride: A Known Irritant and Novel Allergen

The study showed BAK to be an allergen of increasing importance, from 1998 through 2000, 2001 through 2005, and 2006 through 2010, the rate of allergic patch test results to BAK increased, and more than half of the reactions were graded as macular erythema.